Search Results - Kenneth E. Hung
- Showing 1 - 15 results of 15
-
1
-
2
-
3
-
4
Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment by Kenneth E. Hung, Marco Maricevich, Larissa Georgeon Richard, Wei Y. Chen, Michael P. Richardson, Alexandra Kunin, Roderick T. Bronson, Umar Mahmood, Raju Kucherlapati
Published 2010Artigo -
5
Cathepsin B Expression and Survival in Colon Cancer: Implications for Molecular Detection of Neoplasia by Andrew T. Chan, Yoshifumi Baba, Kaori Shima, Katsuhiko Nosho, Daniel C. Chung, Kenneth E. Hung, Umar Mahmood, Karen Madden, Kirtland Poss, Audrey Ranieri, Daniel Shue, Raju Kucherlapati, Charles S. Fuchs, Shuji Ogino
Published 2010Artigo -
6
The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer by Jatin Roper, Michael P. Richardson, Wei Vivian Wang, Larissa Georgeon Richard, Wei Chen, Erin M. Coffee, Mark J. Sinnamon, Lydia Lee, Peng‐Chieh Chen, Roderick T. Bronson, Eric S. Martin, Kenneth E. Hung
Published 2011Artigo -
7
PKM2 is not required for colon cancer initiated by APC loss by Allison N. Lau, William J. Israelsen, Jatin Roper, Mark J. Sinnamon, Larissa Georgeon, Talya L. Dayton, Alissandra L. Hillis, Ömer Yılmaz, Dolores Di Vizio, Kenneth E. Hung, Matthew G. Vander Heiden
Published 2017Artigo -
8
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study by Silvio Danese, Maria Kłopocka, Ellen Scherl, Jacek Romatowski, Jessica R. Allegretti, Elena Peeva, Michael S. Vincent, Uwe Schoenbeck, Ye Zhan, Mina Hassan‐Zahraee, Natalie Rath, Gang Li, Srividya Neelakantan, Christopher Banfield, Christopher Lepsy, Deepa E. Chandra, Kenneth E. Hung
Published 2021Artigo -
9
Concomitant BRAF and PI3K/mTOR Blockade Is Required for Effective Treatment of <i>BRAFV600E</i> Colorectal Cancer by Erin M. Coffee, Anthony C. Faber, Jatin Roper, Mark J. Sinnamon, Gautam Goel, Lily Keung, Wei Vivian Wang, Loredana Vecchione, Veerle de Vriendt, Barbara Weinstein, Roderick T. Bronson, Sabine Tejpar, Ramnik J. Xavier, Jeffrey A. Engelman, Eric S. Martin, Kenneth E. Hung
Published 2013Artigo -
10
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i>-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib by Ryan B. Corcoran, Hiromichi Ebi, Alexa B. Turke, Erin M. Coffee, Michiya Nishino, Alexandria P. Cogdill, Ronald D. Brown, Patricia Della Pelle, Dora Dias‐Santagata, Kenneth E. Hung, Keith T. Flaherty, Adriano Piris, Jennifer A. Wargo, Jeffrey Settleman, Mari Mino‐Kenudson, Jeffrey A. Engelman
Published 2012Artigo -
11
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth by Sergei I. Grivennikov, Kepeng Wang, Daniel Mucida, Charles A. Stewart, Bernd Schnabl, Dominik Jauch, Koji Taniguchi, Guann‐Yi Yu, Christoph H. Österreicher, Kenneth E. Hung, Christian Datz, Ying Feng, Eric R. Fearon, Mohamed Oukka, Lino Tessarollo, Vincenzo Coppola, Felix Yarovinsky, Hilde Cheroutre, Lars Eckmann, Giorgio Trinchieri, Michael Karin
Published 2012Artigo -
12
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis by Mina Hassan‐Zahraee, Zhan Ye, Xi Li, Mary Lynn Baniecki, Xingpeng Li, Craig Hyde, Jenny Zhang, Nancy Raha, Fridrik Karlsson, Jie Quan, Daniel Ziemek, Srividya Neelakantan, Christopher Lepsy, Jessica R. Allegretti, Jacek Romatowski, Ellen Scherl, Maria Kłopocka, Silvio Danese, Deepa E. Chandra, Uwe Schoenbeck, Michael S. Vincent, Randy Longman, Kenneth E. Hung
Published 2021Artigo -
13
Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture by Xingnan Li, Lincoln Nadauld, Akifumi Ootani, David C. Corney, Reetesh K. Pai, Olivier Gevaert, Michael A. Cantrell, Philip D. Rack, James T. Neal, Carol W-M Chan, Trevor M. Yeung, Xue Gong, Jenny Yuan, Julie Wilhelmy, Sylvie Robine, Laura D. Attardi, Sylvia K. Plevritis, Kenneth E. Hung, Chang‐Zheng Chen, Hanlee P. Ji, Calvin J. Kuo
Published 2014Artigo -
14
Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models by Ryan B. Corcoran, Katherine A. Cheng, Aaron N. Hata, Anthony C. Faber, Hiromichi Ebi, Erin M. Coffee, Patricia Greninger, Ronald D. Brown, Jason Godfrey, Travis J. Cohoon, Youngchul Song, Eugene Lifshits, Kenneth E. Hung, Toshi Shioda, Dora Dias‐Santagata, Anurag Singh, Jeffrey Settleman, Cyril H. Benes, Mari Mino‐Kenudson, Kwok‐Kin Wong, Jeffrey A. Engelman
Published 2012Artigo -
15
mTOR Inhibition Specifically Sensitizes Colorectal Cancers with <i>KRAS</i> or <i>BRAF</i> Mutations to BCL-2/BCL-XL Inhibition by Suppressing MCL-1 by Anthony C. Faber, Erin M. Coffee, Carlotta Costa, Anahita Dastur, Hiromichi Ebi, Aaron N. Hata, Alan T. Yeo, Elena J. Edelman, Youngchul Song, Ah Ting Tam, Jessica L. Boisvert, Randy Milano, Jatin Roper, David P. Kodack, Rakesh K. Jain, Ryan B. Corcoran, Miguel N. Rivera, Sridhar Ramaswamy, Kenneth E. Hung, Cyril H. Benes, Jeffrey A. Engelman
Published 2013Artigo
Search Tools:
Related Subjects
Medicine
Biology
Internal medicine
Cancer
Cancer research
Colorectal cancer
Genetics
Gene
Immunology
KRAS
Pathology
Biochemistry
Cell biology
Disease
In vivo
Inflammation
Inflammatory bowel disease
Mutant
PI3K/AKT/mTOR pathway
Apoptosis
Immune system
Signal transduction
Ulcerative colitis
Adenomatous polyposis coli
CD8
Carcinogenesis
Colitis
Cytotoxic T cell
Immunohistochemistry
In vitro